Skip to main content
Log in

AEs impact QOL in patients with metastatic breast cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Hagiwara Y, et al. Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study. PharmacoEconomics : 17 Oct 2017. Available from: URL: http://dx.doi.org/10.1007/s40273-017-0580-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AEs impact QOL in patients with metastatic breast cancer. PharmacoEcon Outcomes News 790, 4 (2017). https://doi.org/10.1007/s40274-017-4449-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4449-y

Navigation